An Evidence-based View on Hyperbilirubinaemia
Overview
Authors
Affiliations
Introduction: We conducted a review of the evidence which contributes to the current care of jaundiced newborn infants.
Methods: Literature was searched for reviews and randomized controlled trials (RCTs).
Results: Six Cochrane reviews and eight other reviews and eighteen recent RCTs are discussed.
Conclusions: Many children still suffer life-long consequences of severe hyperbilirubinaemia, which could almost always have been prevented relatively easily. Up to date, guidelines summarizing the available evidence into unambiguous recommendations are needed to guide healthcare professionals in the prevention, diagnosis and treatment for infants with hyperbilirubinaemia.
Wang Y, Wang H, Zhang Q, Li S, Mao Y, Lu J Front Pediatr. 2023; 11:1200099.
PMID: 37397145 PMC: 10313225. DOI: 10.3389/fped.2023.1200099.
Xue G, Zhang H, Ding X, Xiong F, Liu Y, Peng H BMJ Paediatr Open. 2023; 7(1).
PMID: 37385734 PMC: 10314627. DOI: 10.1136/bmjpo-2023-001924.
Transcutaneous bilirubin level to predict hyperbilirubinemia in preterm neonates.
Rahmawati D, Tri Arif Sampurna M, Etika R, Utomo M, Bos A F1000Res. 2020; 9:300.
PMID: 33014346 PMC: 7499403. DOI: 10.12688/f1000research.22264.2.
Olusanya B, Ogunlesi T, Kumar P, Boo N, Iskander I, de Almeida M BMC Pediatr. 2015; 15:39.
PMID: 25884679 PMC: 4409776. DOI: 10.1186/s12887-015-0358-z.
An hour-specific transcutaneous bilirubin nomogram for Mongolian neonates.
Akahira-Azuma M, Yonemoto N, Mori R, Hosokawa S, Matsushita T, Sukhbat K Eur J Pediatr. 2015; 174(10):1299-304.
PMID: 25869495 PMC: 4575357. DOI: 10.1007/s00431-015-2536-2.